LGND
Ligand Pharmaceuticals Incorporated
301.50$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.01 | 3.39 | 5.23 | 6.01 | 10.45 | 6.09 | 10.11 | 14.01 | 11.63 | 7.40 | 9.14 | 13.21 | |
| 0.43 | 0.27 | 0.27 | 0.23 | 0.26 | 0.57 | 1.88 | 3.61 | 3.13 | 1.97 | 0.61 | 0.32 | |
| 2.58 | 3.11 | 4.96 | 5.78 | 10.18 | 5.51 | 8.23 | 10.40 | 8.50 | 5.42 | 8.53 | 12.89 | |
| 0.57 | 0.63 | 1.02 | 1.15 | 1.16 | 2.83 | 2.50 | 1.86 | 2.14 | 1.38 | 1.17 | 4.00 | |
| 1.05 | 1.15 | 1.28 | 1.22 | 1.57 | 2.12 | 3.71 | 2.71 | 4.15 | 2.97 | 4.30 | 4.56 | |
| 1.62 | 1.78 | 2.81 | 2.88 | 3.38 | -35.34 | 5.91 | 4.38 | 8.32 | 4.75 | 9.77 | 10.56 | |
| 0.92 | 1.29 | 2.11 | 2.90 | 6.80 | 40.85 | 2.32 | 6.02 | 0.18 | 0.67 | -1.24 | 2.33 | |
| 0.23 | 0.56 | 0.58 | 0.49 | 2.01 | 1.81 | 1.69 | 1.14 | 0.11 | 0.04 | 0.17 | 0.23 | |
| 0.53 | 1.66 | 0.38 | 2.44 | 7.20 | 40.32 | 0.08 | 4.19 | 2.13 | 3.59 | 0.14 | 7.83 | |
| 0.02 | -10.34 | 0.50 | 1.90 | 1.25 | 8.47 | -0.33 | -0.24 | 2.44 | 0.55 | 0.36 | 1.70 | |
| 0.56 | 12.12 | -0.08 | 0.53 | 5.96 | 31.85 | -0.18 | 3.31 | -1.98 | 2.94 | -0.22 | 6.13 | |
| 1.09 | 1.41 | 2.65 | 3.46 | 9.90 | 44.34 | 3.50 | 8.28 | 4.81 | 5.68 | 2.23 | 9.50 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.